Clinical trial
A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With…
NCT00477425 · Genentech, Inc., Industry · Withdrawn
Key facts
| NCT number | NCT00477425 |
|---|---|
| Title | A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With Bevacizumab |
| Official title | Evaluation of Corrected QT Interval From Clinical Studies Conducted With Bevacizumab |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Carcinoma |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | May 23, 2007 |
| Last update posted | May 15, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: